Literature DB >> 21417757

HIV variability in the liver and evidence of possible compartmentalization.

Jason T Blackard1, Gang Ma, Christina M Martin, Susan D Rouster, M Tarek Shata, Kenneth E Sherman.   

Abstract

There is growing evidence to suggest that HIV may interact with several hepatic cell types; however, evaluation of HIV variability in liver tissue has not been addressed to date. Among 16 HIV-positive individuals examined, nine (56%) had detectable HIV RNA in the liver. The mean CD4 cell count for these nine individuals was 337 cells/mm(3) (range: 0-601), while their mean plasma HIV RNA level was 106,974 copies/ml (range: 1200-320,740). Among individuals in this study with detectable HIV in both the plasma and the liver, the consensus gag nucleotide sequences for each tissue type were different for seven of seven (100%) individuals, while amino acid sequences were distinct for five of seven (71%). Consensus envelope (env) nucleotide and amino acid sequences were also distinct in the plasma and liver tissue for six of six (100%) individuals. Statistical evidence of compartmentalization between HIV in the plasma and in the liver was demonstrated, and multiple liver-specific amino acids were identified that may distinguish HIV variants replicating within the liver. These preliminary data demonstrate that HIV is frequently detectable in the liver of HIV-positive persons at various levels of immunosuppression. Possible compartmentalization may reflect tissue-specific selection pressures that drive viral adaptation to the liver microenvironment and may facilitate interactions with other hepatotropic viruses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21417757      PMCID: PMC3186706          DOI: 10.1089/aid.2010.0329

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  46 in total

Review 1.  Using HIV-1 sequence variability to explore virus biology.

Authors:  K M McGrath; N G Hoffman; W Resch; J A Nelson; R Swanstrom
Journal:  Virus Res       Date:  2001-08       Impact factor: 3.303

2.  MEGA2: molecular evolutionary genetics analysis software.

Authors:  S Kumar; K Tamura; I B Jakobsen; M Nei
Journal:  Bioinformatics       Date:  2001-12       Impact factor: 6.937

3.  Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing.

Authors:  Loredana Sarmati; Emanuele Nicastri; Ilaria Uccella; Gabriella D'Ettorre; Saverio G Parisi; Lucia Palmisano; Clementina Galluzzo; Ercole Concia; Vincenzo Vullo; Stefano Vella; Massimo Andreoni
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

4.  Substantial correlation between HIV type 1 drug-associated resistance mutations in plasma and peripheral blood mononuclear cells in treatment-experienced patients.

Authors:  H L Devereux; C Loveday; M Youle; C A Sabin; A Burke; M Johnson
Journal:  AIDS Res Hum Retroviruses       Date:  2000-07-20       Impact factor: 2.205

5.  Subcompartmentalization of HIV-1 quasispecies between seminal cells and seminal plasma indicates their origin in distinct genital tissues.

Authors:  Shirish Paranjpe; Jodi Craigo; Bruce Patterson; Ming Ding; Paulo Barroso; Lee Harrison; Ronald Montelaro; Phalguni Gupta
Journal:  AIDS Res Hum Retroviruses       Date:  2002-11-20       Impact factor: 2.205

6.  A cladistic measure of gene flow inferred from the phylogenies of alleles.

Authors:  M Slatkin; W P Maddison
Journal:  Genetics       Date:  1989-11       Impact factor: 4.562

Review 7.  Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences.

Authors:  Jason T Blackard; Daniel E Cohen; Kenneth H Mayer
Journal:  Clin Infect Dis       Date:  2002-03-15       Impact factor: 9.079

8.  Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity.

Authors:  Kalonji R Collins; Miguel E Quiñones-Mateu; Mianda Wu; Henry Luzze; John L Johnson; Christina Hirsch; Zahra Toossi; Eric J Arts
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

9.  HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women.

Authors:  Jason T Blackard; Jeffrey A Welge; Lynn E Taylor; Kenneth H Mayer; Robert S Klein; David D Celentano; Denise J Jamieson; Lytt Gardner; Kenneth E Sherman
Journal:  Clin Infect Dis       Date:  2011-01-19       Impact factor: 9.079

10.  Impact of highly active antiretroviral therapy on the spectrum of liver disease in HCV-HIV coinfection.

Authors:  Richard K Sterling; Mary S Wilson; Arun J Sanyal; Velimir A Luketic; R Todd Stravitz; Melissa J Contos; A Scott Mills; Mitchell L Shiffman
Journal:  Clin Gastroenterol Hepatol       Date:  2004-05       Impact factor: 11.382

View more
  5 in total

Review 1.  Understanding HIV compartments and reservoirs.

Authors:  Valentina Svicher; Francesca Ceccherini-Silberstein; Andrea Antinori; Stefano Aquaro; Carlo Federico Perno
Journal:  Curr HIV/AIDS Rep       Date:  2014-06       Impact factor: 5.071

2.  Analysis of HIV quasispecies suggests compartmentalization in the liver.

Authors:  Patricia K Penton; Jason T Blackard
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-25       Impact factor: 2.205

Review 3.  Tissue reservoirs of HIV.

Authors:  Joseph K Wong; Steven A Yukl
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

4.  Low-level HIV infection of hepatocytes.

Authors:  Ling Kong; Walter Cardona Maya; Maria E Moreno-Fernandez; Gang Ma; Mohamed T Shata; Kenneth E Sherman; Claire Chougnet; Jason T Blackard
Journal:  Virol J       Date:  2012-08-09       Impact factor: 4.099

Review 5.  Pancreatogenic Diabetes: Triggering Effects of Alcohol and HIV.

Authors:  Moses New-Aaron; Murali Ganesan; Raghubendra Singh Dagur; Kusum K Kharbanda; Larisa Y Poluektova; Natalia A Osna
Journal:  Biology (Basel)       Date:  2021-02-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.